Caricamento...
Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes
OBJECTIVE: To determine whether IV immunoglobulin (IVIg) is more effective than placebo at reducing disability in patients with diabetes and demyelinating polyneuropathy features. METHODS: This is a double-blinded, single-center, randomized, controlled crossover trial of IVIg treatment vs placebo. T...
Salvato in:
| Pubblicato in: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6943235/ https://ncbi.nlm.nih.gov/pubmed/31454771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000586 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|